Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bardelli

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
The EMBO Journal|October 1, 1991
Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptorL Naldini, K M Weidner, E Vigna, et al.
Oncogene|April 20, 1995
The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor proteinG Pelicci, S Giordano, Z Zhen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2019
How liquid biopsies can change clinical practice in oncologyG Siravegna, B Mussolin, T Venesio, et al.
International Journal of Cancer|July 27, 1999
Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC familyM Olivero, G Valente, A Bardelli, et al.
Science (New York, N.Y.)|October 13, 2001
A phosphatase associated with metastasis of colorectal cancerS Saha, A Bardelli, P Buckhaults, et al.
Molecular and Cellular Biology|May 1, 1996
The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase CgammaM G Borrello, L Alberti, E Arighi, et al.
Cancer Treatment Reviews|December 7, 2010
Therapeutic implications of resistance to molecular therapies in metastatic colorectal cancerA Sartore-Bianchi, K Bencardino, A Cassingena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2011
Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study)C Pinto, F Di Fabio, E Maiello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2017
Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitorG Siravegna, A Sartore-Bianchi, B Mussolin, et al.
Oncogene|May 28, 2008
AKT1(E17K) in human solid tumoursF E Bleeker, L Felicioni, F Buttitta, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
The EMBO Journal|October 1, 1991
Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptorL Naldini, K M Weidner, E Vigna, et al.
Oncogene|April 20, 1995
The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor proteinG Pelicci, S Giordano, Z Zhen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 3, 2019
How liquid biopsies can change clinical practice in oncologyG Siravegna, B Mussolin, T Venesio, et al.
International Journal of Cancer|July 27, 1999
Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC familyM Olivero, G Valente, A Bardelli, et al.
Science (New York, N.Y.)|October 13, 2001
A phosphatase associated with metastasis of colorectal cancerS Saha, A Bardelli, P Buckhaults, et al.
Molecular and Cellular Biology|May 1, 1996
The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase CgammaM G Borrello, L Alberti, E Arighi, et al.
Cancer Treatment Reviews|December 7, 2010
Therapeutic implications of resistance to molecular therapies in metastatic colorectal cancerA Sartore-Bianchi, K Bencardino, A Cassingena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2011
Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study)C Pinto, F Di Fabio, E Maiello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2017
Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitorG Siravegna, A Sartore-Bianchi, B Mussolin, et al.
Oncogene|May 28, 2008
AKT1(E17K) in human solid tumoursF E Bleeker, L Felicioni, F Buttitta, et al.
Pageof 6